- Home
- GIW vs LFCR Comparison
GIW vs LFCR Comparison
Compare GIW & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$7.89
Company Overview
Basic Information| Metric | GIW | LFCR |
|---|---|---|
| Founded | 2025 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 361.6M | 296.0M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | GIW | LFCR |
|---|---|---|
| Price | $9.89 | $7.89 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | ★ 154.1K | 145.9K |
| Earning Date | 01-01-0001 | 01-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $128,867,000.00 |
| Revenue This Year | N/A | $2.80 |
| Revenue Next Year | N/A | $11.51 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 0.47 |
| 52 Week Low | $9.88 | $4.76 |
| 52 Week High | $10.05 | $8.85 |
Technical Indicators
Market Signals| Indicator | GIW | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 59.10 |
| Support Level | N/A | $7.34 |
| Resistance Level | N/A | $7.87 |
| Average True Range (ATR) | 0.00 | 0.26 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 0.00 | 90.48 |
Price Performance
Historical Comparison GIW
LFCR
About GIW GigCapital8 Corp. Class A Ordinary Shares
GigCapital8 Corp is a special purpose acquisition company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.